PYC Therapeutics Limited (ASX:PYC)
1.725
-0.065 (-3.63%)
Nov 17, 2026, 11:20 AM AEDT
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 1.7 billion as of November 16, 2026. It is the 8,932nd most valuable company in the world and the 163rd biggest in Australia. Its market cap has increased by 144.61% in one year.
Market Cap
1.70B
Enterprise Value
1.25B
Revenue
25.99M
Global Rank
Country Rank
#163 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 1.70B, an increase of 5,953.79%. That is a compound annual growth rate of 20.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.81B | 87.10% |
| Dec 31, 2025 | 965.30M | 56.72% |
| Dec 31, 2024 | 615.92M | 50.00% |
| Dec 29, 2023 | 410.62M | 87.08% |
| Dec 30, 2022 | 219.48M | -48.89% |
| Dec 31, 2021 | 429.43M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.59B |
| Neuren Pharmaceuticals | 2.91B |
| Mesoblast | 2.45B |
| Clarity Pharmaceuticals | 680.87M |
| Clinuvel Pharmaceuticals | 382.24M |
| Tetratherix | 339.57M |
| Racura Oncology | 323.51M |
| Starpharma Holdings | 203.89M |